Company Description
Abzena is the leading end-to-end bioconjugate (ADC, AOC, RDC) & complex biologics CDMO + CRO. From discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development of new treatments for patients in need. With the ability to tailor our strategy and customer experience to each project, Abzena develops and implements innovative solutions that enable biotech and biopharma companies to realize the full potential of their molecule.
Over the past 24 years, Abzena has helped hundreds of customers ranging from emerging biotechs to the top large pharmaceutical firms achieve their regulatory and clinical milestones. With extensive scientific knowledge and technical expertise, our global teams provide customers with comprehensive support that minimizes risks and moves new medicines forward faster—with greater success. Our global locations include San Diego (CA, USA), Bristol (PA, USA), and Cambridge (UK).
Company Background
- Founded in 2001
- 450+ Employees
- 500+ Customers Globally
- 150 Programs Delivered Across R&D and CMC Per Year
- 200+ High-Performing Cell Lines Developed
- 2000+ Bioconjugates Developed
- 3000+ Linker-Payloads Designed & Synthesized
Facilities
We have footholds in both the US & UK with five sites in total. Three facilities are located in San Diego, CA, one in Bristol, PA, and one in Cambridge, UK.
Our Cambridge, UK site specializes in early discovery, design and developability services to select the best lead candidate for development for both complex biologics and bioconjugates.
Our San Diego facilities are dedicated to the development and manufacture of biologics with specialties in process development, analytics and cGMP manufacturing from clinical to commercial scale up to 2000L.
Our Bristol, PA site provides preclinical through commercial manufacturing support for bioconjugate drug programs including ADCs/AOCs/RACs/RDCs and conjugate vaccines.
Services and Capabilities
Abzena develops and implements fully integrated services and tailored, innovative solutions that are designed to rapidly advance your program to its next milestone.
- Lead Discovery, Design and Selection
- Robust Analytics, Bioassays and Immunogenicity
- Antibody Engineering and Developability
- Bioconjugation and Complex Chemistry
- Mammalian Cell Line Development
- Linker Payload Design and Synthesis
- Analytical Method & Formulation Development
- Process Development and cGMP Manufacturing
- Technology Transfer & Scale-Up
- Regulatory Support